Dr. David Steensma, MD

• Hematology

• Medical Oncology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Chicago Hospital / Roosevelt University

  Medical School, 1997

• Clinical response to ruxolitinib inCSF3R T618-mutated chronic neutrophilic leukemia, 2016-04-11

• Fit Older Adults with Advanced Myelodysplastic Syndromes: Who is Most Likely to Benefit from Transplant?, 2020-11-17

• Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions, 2016-12-07

• New Strategies in Myelodysplastic Syndromes:Application of molecular diagnostics to clinical practice, 2013-01-17

• Blood and Marrow Transplant Clinical Trials Network Study 1102 Heralds a New Era in Hematopoietic Cell Transplantation in High Risk Myelodysplastic Syndromes: Challenges and Opportunities in Implementation, 2021-08-10

• Myelodysplastic syndromes (MDS) occurring in Agent Orange exposed individuals carry a mutational spectrum similar to that ofde novoMDS, 2019-11-12

• Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium, 2020-12-22

• A Phase I Study of Lenalidomide plus Chemotherapy with Mitoxantrone, Etoposide, and Cytarabine for the Reinduction of Patients with Acute Myeloid Leukemia, 2017-11-21

• Outcome of Patients With Low-Risk and Intermediate-1-Risk Myelodysplastic Syndrome After Hypomethylating Agent Failure A Report on Behalf of the MDS Clinical Research Consortium, 2014-11-19

• Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study, 2016-08-19

• Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant, 2020-06-12

• Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms, 2021-06-25

• Myelodysplastic Syndrome Associated with Acquired Beta Thalassemia: "BTMDS”, 2016-07-04

• Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS), 2012-04-30

• Oncologists' Reluctance to Use the TermsHopeandCure: A Bibliometric Analysis of Articles From Two High-Impact Oncology Journals, 2020-08-14

• Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms, 2018-04-11

• Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better?, 2015-08-11

• The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes, 2022-09-24

• Myelodysplastic syndromes current treatment algorithm 2018, 2018-05-24

• Health Care Utilization and End of Life Care for Older Patients with Acute Myeloid Leukemia, 2015-04-29

• Differential response to hypomethylating agents based on sex: a report on behalf of the MDS Clinical Research Consortium (MDS CRC), 2016-10-24

• Outcomes for Older Adults with Acute Myeloid Leukemia After an Intensive Care Unit Admission, 2019-07-12

• Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adults, 2015-06-11

• Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect®MDS/AML Disease Registry, 2020-06-30

• A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML), 2016-02-08

• Wide Variations in Blood Product Transfusion Practices among Providers Who Care for Patients with Acute Leukemia in the United States, 2016-11-22

• Real-world diagnostic testing patterns for assessment of ring sideroblasts andSF3B1mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes, 2020-11-21

• A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets, 2013-11-27

• Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia, 2021-07-12

• Targeting aberrant splicing in myelodysplastic syndromes: biologic rationale and clinical opportunity, 2019-12-11

• The Public Repository of Xenografts (ProXe) enables discovery and randomized phase II-like trials in mice, 2016-04-11